Skip to Content

Qilu Synva Pharmaceutical, China, 2024

GMP Audit Report

Company
Qilu Synva Pharmaceutical

Product(s)
Ceftiofur iorhidrato

Country
China

Audit Year
2024

0.00 € 0.00 €
0.00 €